On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating. This revision follows a revenue ...

H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while ...

In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against other best penny stocks to buy according to the media. On December 24, Global Advisors’ managing ...

Invivyd, Inc. (NASDAQ: IVVD) secures $30M loan facility with Silicon Valley Bank for future capital drawdowns and aims for near-term profitability. Lekha Gupta FDA Rejects Invivyd's Request To ...

INVIVYD ($IVVD) is expected to release its quarterly earnings data on Thursday, May 15th before market open, per Finnhub. Analysts are expecting revenue of ...

So, naturally, I’ll be going through all the essentials to figure out whether IVVD is actually worth the gamble for a potential payoff. Invivyd’s latest preliminary fourth-quarter 2024 results ...

In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other micro and small-cap stocks. Nine micro-cap companies and one small-cap firm have been the ...

NASDAQ:IVVD opened at $0.72 on Thursday. Invivyd has a 52 week low of $0.35 and a 52 week high of $4.74. The firm has a market cap of $86.12 million, a price-to-earnings ratio of -0.37 and a beta ...

Invivyd (NASDAQ:IVVD) just reported results for the second quarter of 2024. Invivyd reported earnings per share of -40 cents. This was below the analyst estimate for EPS of -36 cents. The company ...

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today ...